Prof. Wei Tao is the Farokhzad Family Distinguished Chair for Innovation (Endowed Chair) and Principal Investigator in the Center for Nanomedicine, Faculty Member in the Department of Anesthesiology, Perioperative, and Pain Medicine, and Faculty Member in the Gillian Reny Stepping Strong Center for Trauma Innovation at Brigham and Women’s Hospital (BWH), Harvard Medical School (HMS). He is also the first Distinguished Chair professor as an assistant professor in his institution. He has been named Clarivate’s Global Highly Cited Researcher continuously since 2021. Prof. Tao’s research interests include biomaterials, nanotechnology and drug delivery, as well as their various applications in translational medicine.
Prof. Tao has received multiple awards/grants including the American Heart Association (AHA) Transformational Project Award, American Lung Association (ALA) Courtney Cox Cole Lung Cancer Research Award, AHA Collaborative Sciences Award, ALA Cancer Discovery Award, American Society of Transplantation (AST) Career Transition Grant, Novo Nordisk ValidatioNN Award, Harvard/Brigham Health Technology Innovator Award, Anaesthesia Department Basic Scientist Grant, Khoury Innovation Award, Center for Nanomedicine Research Fund, Nanotechnology Foundation, Stepping Strong Breakthrough Innovator Award, AHA's Second Century Early Faculty Independence Award, U.S. METAvivor Early Career Investigator Award, MIT Technology Review Top Chinese Innovators Under 35 (2020 TR35), World's Top 2% Scientist (continuously selected since 2019), Chemical Society Reviews (IF~46) Emerging Investigator Award, Advanced Materials (IF~30) Rising Star, Materials Today (IF~24) Rising Star Award, Angewandte Chemie (IF~17) Most Outstanding Referees Award, Materials Horizons (IF~13) Top 10 Outstanding Reviewers Award, etc. He also serves on numerous editorial boards including as Founding Editor-in-Chief of Biomedical Technology (Elsevier, KeAi's new journal), Deputy Editor of Exploration (Wiley's new journal), Associate Editor of Journal of Nanobiotechnology (IF~10; Springer Nature & BMC) and Aggregate (IF~19; Wiley); Editor of PNAS (IF~11); Guest Editor of eLife, etc.; Senior Editorial Board Member of Materials Today (IF~24, Elsevier), Bioactive Materials (IF~19; Elsevier, KeAi), Nano-Micro Letters (IF~27; Springer Nature), etc.; and Advisory Board Member of Matter (IF~19; Cell Press).
See Prof. Tao's interview (together with Prof. Robert Langer/MIT, Prof. Samir Mitragotri/Harvard, Dr. Nicholas Warne/Pfizer, Dr. Steffen Panzner/BioNTech, etc.) in Nature Medicine (https://www.nature.com/articles/s41591-022-01826-y).
List of Research Areas:
Biomaterials, RNA Medicine, Drug Delivery, Biomedical Engineering, Nanomedicine.